Scholarlink

Background <p>Vestibular schwannomas (VS) are benign tumors of the eighth cranial nerve. While gross total resection (GTR) is often achieved in primary surgery, recurrence remains a therapeutic challenge. Repeat microsurgery is a key treatment option, but evidence is limited and inconsistently reported. This study systematically synthesizes current data on outcomes after repeat microsurgical resection for recurrent VS.</p> Methods <p>A systematic PubMed search identified studies reporting outcomes of repeat microsurgery for recurrent VS. Extracted data included patient characteristics, GTR rate, progression-free survival (PFS), facial nerve function (House–Brackmann scale), hearing preservation, postoperative complications, and hydrocephalus or shunt dependency. Pooled analyses using random-effects models estimated summary proportions across studies.</p> Results <p>Ten studies including 359 patients met inclusion criteria. The pooled GTR rate was 0.71 (95% CI: 0.46–0.87). Four studies (49 patients) reported PFS, with no tumor recurrences (pooled proportion = 1.00). Postoperative facial nerve deterioration occurred in 43% (95% CI: 0.29–0.58). Cerebrospinal fluid (CSF) leakage was the most frequent complication (11% (95% CI: 0.05–0.21)). Between-study heterogeneity was low to moderate in most of the studies (I² = 0–38.6%).</p> Conclusions <p>Repeat microsurgery for recurrent VS provides good tumor control but carries higher risks of facial nerve deterioration and other complications compared with primary surgery. Current evidence is limited by small cohorts and retrospective designs. Standardized reporting and prospective multicenter studies are required to improve treatment strategies for this rare and challenging condition.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Salvage surgery following primary treatment in recurrent vestibular schwannoma: surgical outcomes and progression-free survival- a meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月29日

查看全文
  • Lisa Haddad,
  • Felix Arlt,
  • Erdem Güresir,
  • Johannes Wach

摘要

Background

Vestibular schwannomas (VS) are benign tumors of the eighth cranial nerve. While gross total resection (GTR) is often achieved in primary surgery, recurrence remains a therapeutic challenge. Repeat microsurgery is a key treatment option, but evidence is limited and inconsistently reported. This study systematically synthesizes current data on outcomes after repeat microsurgical resection for recurrent VS.

Methods

A systematic PubMed search identified studies reporting outcomes of repeat microsurgery for recurrent VS. Extracted data included patient characteristics, GTR rate, progression-free survival (PFS), facial nerve function (House–Brackmann scale), hearing preservation, postoperative complications, and hydrocephalus or shunt dependency. Pooled analyses using random-effects models estimated summary proportions across studies.

Results

Ten studies including 359 patients met inclusion criteria. The pooled GTR rate was 0.71 (95% CI: 0.46–0.87). Four studies (49 patients) reported PFS, with no tumor recurrences (pooled proportion = 1.00). Postoperative facial nerve deterioration occurred in 43% (95% CI: 0.29–0.58). Cerebrospinal fluid (CSF) leakage was the most frequent complication (11% (95% CI: 0.05–0.21)). Between-study heterogeneity was low to moderate in most of the studies (I² = 0–38.6%).

Conclusions

Repeat microsurgery for recurrent VS provides good tumor control but carries higher risks of facial nerve deterioration and other complications compared with primary surgery. Current evidence is limited by small cohorts and retrospective designs. Standardized reporting and prospective multicenter studies are required to improve treatment strategies for this rare and challenging condition.